跳至主要内容
临床试验/KCT0007074
KCT0007074招募中未知

The effect of anesthetic agent (remimazolam versus etomidate) on post-induction hypotension associated with general anesthesia in coronary artery bypass surgery: Non-inferiority randomized controlled study

Samsung Medical Center0 个研究点目标入组 148 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
148

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 75(Year)(—)
性别
All

入选标准

  • 1) Adults who are American society of anesthesia (ASA) class III~IV
  • 2) Patients undergoing coronary artery bypass grafting

排除标准

  • 1) Patients with a history of allergy or hypersensitivity to benzodiazepines or etomidate drugs
  • 2) Patients with severe hepatic impairment, such as, patients with Child-Pugh classifications B and C and patients with chronic renal disease
  • 3) Patients with low ejection fraction ( =40%)
  • 4) Patients with diagnosed adrenocortical insufficiency of taking glucocorticoids within 6 months, if ever used

研究者

相似试验